Randomized controlled trial of dialyzer used by dialysis initiation patients with discontinuation of production of EVAL membrane dialyzer

Randomized controlled trial of dialyzer used by dialysis initiation patients with discontinuation of production of EVAL membrane dialyzer - Initiating dialyzer trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047538

Enrollment

Registered

2022-05-01

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure

Interventions

Treatment with one dialyzer chosen from NF-U. Treatment with one dialyzer chosen from.FDX Treatment with one dialyzer chosen from .PES-Galpha. Treatment with one dialyzer chosen from.VPS-HA.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis initiation patients Patients >= 20 years and <85 years of age at the time of informed consent.

Exclusion criteria

Exclusion criteria: Medical history of the peritoneal dialysis. Difficulties for self-management. Patients who are going to be transferred to another hospital. Patients in the opinion of the principal investigator to disqualify from participation.

Design outcomes

Primary

Measure	Time frame
Indefinite complaint and nutritional status 0, 2, 6, 12 months after dialysis initiation.	—

Secondary

Measure	Time frame
3 years survival rate after dialysis initiation. Residual renal function 0, 2, 6, 12 months after dialysis initiation.	—

Countries

Japan

Contacts

Public ContactNorio Suzuki

Medical corporation Seieikai Department of clinical engineering

suzukin@seieig.or.jp023-615-1877

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026